Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for a study of extended-release exenatide and albuminuria in people with type 2 diabetes is displayed, with study details, participation criteria, outcomes, and a study protocol document.
    Difference
    47%
    Check dated 2026-11-09T13:48:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:58:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH website transition and links to updates and FAQs, noting a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T14:52:48.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:43:21.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:41.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record content, with a header and navigation visible. This indicates an access restriction rather than data updates for the study.
    Difference
    18%
    Check dated 2026-09-21T22:12:39.000Z thumbnail image

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.